A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaPaul G. Richardson, Kenneth C. Anderson|New England Journal of Medicine|2003Cited by 2.6k
International uniform response criteria for multiple myelomaBrian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al.|Leukemia|2006Cited by 2.6k
Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Kouros Owzar et al.|New England Journal of Medicine|2012Cited by 1.1k
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPhilippe Moreau, Paul G. Richardson|New England Journal of Medicine|2016Cited by 1.1k
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolò Bolli, Nikhil C. Munshi, Hervé Avet‐Loiseau et al.|Nature Communications|2014Cited by 906